mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.02 |
mRNA |
L-685458 |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.03 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.03 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.03 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.03 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |